Previous 10 | Next 10 |
Corbus Pharmaceuticals (NASDAQ:CRBP): Q2 GAAP EPS of -$0.15 misses by $0.03. Revenue of $0.14M (-53.3% Y/Y) misses by $0.57M. Shares -1.5% PM. Press Release Cash and investments on hand of $114M provides projected runway into first quarter of 2024 For further details see: Corbus Pharmac...
Company focused on gaining regulatory clarity for late-stage lenabasum program and advancing programs targeting the endocannabinoid system and integrin s into the clinic Augmenting the pipeline through business development continues to...
7 Top Penny Stocks That Investors Are Watching in July 2021 Creating a penny stocks watchlist is one of the most crucial steps to investing in small caps. While many choose to find penny stocks on Reddit or other social media sites, using research and information to create a watchli...
Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...
Marin Software (MRIN) -14%.Oasis Midstream Partners (OMP) -11% on proposed public offering.Corbus Pharmaceuticals (CRBP) -8%.Happiness Biotech (HAPP) -8% on $2.16M public offering For further details see: Oasis Midstream Partners, Corbus Pharmaceuticals among premark...
PashaIgnatov/iStock via Getty Images The trading of Corbus Pharmaceuticals Holdings (CRBP) shares is currently on hold after the company announced that its Phase 3 study of lenabasum in adults with dermatomyositis failed to meet the primary endpoint of Total Improvement Score ((TIS)...
Study did not meet primary endpoint of Total Improvement Score (TIS) at Week 28 Additional findings included nominally significant improvements in TIS (p = 0.0302) and CDASI (p = 0.0166) depending on the dermatomyositis subtype Lenabasum treatment was safe and well-tolerated in th...
At the conclusion of the 2021 Russell indexes annual reconstitution following notable healthcare stocks will join the Russell 3000 Index, effective June 28 after the U.S. market opens.Bionano Genomics (BNGO), Asensus Surgical (ASXC), Ocugen (OCGN), Senseonics Holdings (SEN...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips PSY (NYSEARCA: PSY ) is getting extra attention on Monday as investors seek out investments in the psychedelic medical market. Source: luckakcul / Shutterstock.com Here’s everything investors interested...
The following slide deck was published by Corbus Pharmaceuticals Holdings, Inc. in conjunction with this event. For further details see: Corbus Pharmaceuticals (CRBP) Investor Presentation - Slideshow
News, Short Squeeze, Breakout and More Instantly...
Corbus Pharmaceuticals Holdings Inc. Company Name:
CRBP Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States SOBR Safe Inc. (SOBR) rose 115.1% to $0.5667 on volume of 77,631,052 shares MicroAlgo Inc. (MLGO) rose 284.0% to $5.99 on volume of 40,752,997 shares Crown Electrokinetics Corp. (CRKN) fell 13.8% to $0.1016 on volume of 28,247,104 sha...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 22.3% to $0.12231 on volume of 147,748,197 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 11.8% to $0.6524 on volume of 95,235,738 shares AMC Entertainment Holdings Inc. Class A (AM...
An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacy SYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR and 86% DCR in cervical cancer to date at doses ≥ 1.2mg/Kg No dose limiting t...